Novartis is undergoing a restructuring that it expects will save the company $1 billion by 2024
AG said Monday that it is undergoing a restructuring that it expects will save the company $1 billion by 2024. Several of the Swiss pharmaceutical company’s top management, including its chief medical officer, will be leaving, the company said.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Novartis to save at least $1 bln by 2024 thanks to simplified structureNovartis said on Monday it was integrating its pharmaceuticals and oncology units into an innovative medicines (IM) business to simplify its structure, targeting savings of at least $1 billion by 2024.
Lire la suite »
AOC's campaign and ex-chief of staff failed to disclose $1 million in expensesThe campaign of New York Rep. Alexandria Ocasio-Cortez and her former chief of staff were found to have failed to report roughly $1 million in expenses.
Lire la suite »
U.S. Authorities Seized More Than $1 Million in Looted Asian Antiquities From Yale University | Artnet NewsU.S. Homeland Security agents seized more than a dozen looted Asian antiquities, valued at $1.29 million, from Yale University in Connecticut:
Lire la suite »
Bojangles giving away $1 million worth of gas cardsA popular southern fast-food chain is serving up $1 million worth of gas gift cards as a way to help families deal with rising gas prices.
Lire la suite »
Musk, Dorsey Add Nearly $1 Billion To Fortunes As Twitter Stock Surges 27%Elon Musk’s surprise disclosure about his new investment in Twitter sent the shares soaring, boosting departed founder Jack Dorsey’s net worth, too.
Lire la suite »
Close to 250 Casascius Physical Bitcoins Were Redeemed in 6 Months, $1.9B in BTC Remain Active – Featured Bitcoin NewsSince September 18, 2021, close to 250 Casascius physical bitcoins were redeemed over the last 198 days, which leaves 19,676 left to peel. BTC
Lire la suite »